Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

565 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes.
Yang SJ, Min KW, Gupta SK, Park JY, Shivane VK, Pitale SU, Agarwal PK, Sosale A, Gandhi P, Dharmalingam M, Mohan V, Mahesh U, Kim DM, Kim YS, Kim JA, Kim PK, Baik SH. Yang SJ, et al. Among authors: gandhi p. Diabetes Obes Metab. 2013 May;15(5):410-6. doi: 10.1111/dom.12042. Epub 2012 Dec 17. Diabetes Obes Metab. 2013. PMID: 23170990 Clinical Trial.
Consensus Statement on Management of Post-Prandial Hyperglycemia in Clinical Practice in India.
Aravind S, Saboo B, Sadikot S, Shah SN, Makkar B, Kalra S, Kannampilly J, Kesavadev J, Ghoshal S, Zargar A, Nigam A, Hazra D, Tripathi K, Dharmalingam M, Shah P, Gandhi P, Sahay R, Unnikrishnan R, Gupta S, Bajaj S, Mukhopadhyay S, Kale S. Aravind S, et al. Among authors: gandhi p. J Assoc Physicians India. 2015 Aug;63(8):45-58. J Assoc Physicians India. 2015. PMID: 27604435
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Clinical and Demographic Profile of Diabetic Patients from Central India - Results from Diabetes Registry.
Pitale S, Sahasrabuddhe A, Gandhi P, Joshi P, Sakhare A, Balankhe N, Khobragade S, Sengupta S, Ambulkar S, Ganeriwal M, Shembalkar J, Naidu S. Pitale S, et al. Among authors: gandhi p. Indian J Endocrinol Metab. 2022 Sep-Oct;26(5):471-477. doi: 10.4103/ijem.ijem_63_22. Epub 2022 Nov 22. Indian J Endocrinol Metab. 2022. PMID: 36618524 Free PMC article.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators. Sherry N, et al. Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719095 Free PMC article. Clinical Trial.
Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion.
Das AK, Gandhi P, Saboo B, Reddy S, Chawla R, Zargar AH, Kovil R, Chawla M, Sharma SK, Gupta S, Makkar BM, Mittal V, Goswami S, Arvind SR, Jaggi S, Bajaj S, Das S. Das AK, et al. Among authors: gandhi p. J Family Med Prim Care. 2021 Dec;10(12):4398-4409. doi: 10.4103/jfmpc.jfmpc_2378_20. Epub 2021 Dec 27. J Family Med Prim Care. 2021. PMID: 35280631 Free PMC article. Review.
565 results